Skip to main content

Table 6 Uterine fibroid symptom severity (UFS-QoL) overall summary

From: The safety and effectiveness of volumetric magnetic resonance-guided high-intensity focused ultrasound treatment of symptomatic uterine fibroids: early clinical experience in China

   

Months post treatment

UFS-QoL parameter

Statistic

Screening

(N = 107)

1

(N = 107)

3

(N = 102)

6

(N = 100)

SSS transformeda

 

Mean (SD)

34.4 (14.70)

28.1 (15.00)

27.2 (15.70)

24 (16.10)

 

95 % CI

(31.6, 37.2)

(25.2, 30.9)

(24.2, 30.3)

(20.8, 27.2)

HRQL transformeda

 

Mean (SD)

73 (18.80)

78.1 (18.00)

78.5 (19.50)

82.2 (17.30)

 

95 % CI

(69.4, 76.6)

(74.7, 81.6)

(74.7, 82.4)

(78.7, 85.6)

Total score

 

Mean (SD)

79.3 (25.10)

71.3 (24.40)

70.6 (26.10)

65.4 (24.30)

 

95 % CI

(74.5, 84.1)

(66.7, 76)

(65.5, 75.7)

(60.5, 70.2)

  1. SSS symptom severity score, HRQL health-related quality of life
  2. aTransformed scores (SSS and HRQL) can range from 0 to 100. The total score ranges from 37 to a maximum of 185